8. Huntington disease Clinical trials / Disease details
Clinical trials : 242 / Drugs : 205 - (DrugBank : 62) / Drug target genes : 85 - Drug target pathways : 159
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00190450 (ClinicalTrials.gov) | January 2002 | 15/9/2005 | MIG-HD: Multicentric Intracerebral Grafting in Huntington's Disease | Multicentric Intracerebral Grafting in Huntington's Disease | Huntington Disease | Biological: graft intracerebral of foetal neurons | Assistance Publique - Hôpitaux de Paris | NULL | Completed | 18 Years | 65 Years | All | 54 | Phase 2 | France |